Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole PK and Sex Influence Pilot Study
NCT03760276Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2018
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of voriconazole in fungal infection, sponsored by Seoul National University Hospital. Primary endpoints: Peak Plasma Concentration at Day 7 and Area Under the Plasma Concentration-Time Curve at Day 7. Started Aug 2018; status: completed.
02
Drugs
voriconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT03760276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03760276.